Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Carbonylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Pd-catalyzed multicomponent route for indolinone-imidazole scaffolds. Safe, scalable, CO-free process for high-purity pharmaceutical intermediates.
Patent CN117164544A reveals a novel palladium-catalyzed method for pyrone derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN119161318A reveals mild Pd-catalyzed route for benzopyran amides. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel carbonylation method using sulfonyl chlorides avoids thiols. High purity API intermediates with scalable, cost-effective production capabilities.
Patent CN113735826A reveals a novel Pd-catalyzed carbonylation route for 3-benzylidene-2,3-dihydroquinolones, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel palladium-catalyzed carbonylation method for polycyclic quinolinones. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Patent CN115286628B reveals efficient one-step carbonylation. Delivers high-purity pharmaceutical intermediates with substantial cost reduction and supply chain reliability.
Novel palladium-catalyzed carbonylation patent CN114751883B enables cost reduction in API manufacturing and high-purity benzofuran derivatives supply.
Patent CN113735826B details palladium-catalyzed carbonylation for high-purity intermediates. Offers cost reduction and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN112480015B details a novel one-pot synthesis of 2-trifluoromethyl quinazolinones using nitro compounds. This method offers significant cost reduction in API manufacturing and enhanced supply chain reliability for pharmaceutical intermediates.
Patent CN115286553B reveals nickel-catalyzed carbonylation for indole synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel nickel-catalyzed carbonylation method for 2-pyrrolidone derivatives offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115246786B details a palladium-catalyzed carbonylation method for indole and benzoxazine compounds, offering scalable routes and cost advantages for pharmaceutical intermediate manufacturing.
Patent CN112239456B details a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolones, offering reliable pharmaceutical intermediate supply and cost reduction.
Novel carbonylation route for pyrrol-2-one scaffolds offers high efficiency and substrate tolerance for pharmaceutical manufacturing.
Novel Pd-catalyzed carbonylation method for 2-trifluoromethyl quinazolinones. High yield, scalable route for API intermediates like Rutaecarpine.
Patent CN112480015B reveals a Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering cost reduction in API manufacturing and scalable production capabilities.
Novel palladium-catalyzed carbonylation method offers significant cost reduction in pharmaceutical intermediates manufacturing with high purity and scalable production capabilities for global supply chains.
Novel CuCl-catalyzed route for 1,2,4-triazolyl arylamines. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Patent CN114478375A reveals a novel Pd-catalyzed route to 3-alkenyl quinolin-2(1H)ones using allyl aryl ethers, offering safer carbonylation and cost reduction in API manufacturing.